Medisafe’s Digital Companion Launch Toolkit

Breast cancer remains one of the most prevalent malignancies worldwide, with an estimated 287,850 new invasive cases and 43,250 breast cancer–related deaths projected in the United States in 2025 (American Cancer Society, 2025). Despite advances in targeted oral therapies for extended adjuvant treatment, real‐world studies find that up to 50% of patients discontinue or skip doses, undermining efficacy (Mayo Clinic, 2024).

Leading pharmaceutical companies are now using AI to help healthcare providers simplify and streamline the patient experience for specialty medications, which can be difficult to access, adhere to, and afford.

Medisafe has pioneered an ecosystem of digital solutions aimed at addressing critical Pharma challenges. The Medisafe Digital Companion stands out as a comprehensive tool that provides personalized medication management, reminders, and educational content. Research indicates that Medisafe users exhibit improved medication adherence rates, with some studies showing an adherence rate increase of over 20%.